Company Filing History:
Years Active: 2011
Title: Michael Ankerson: Innovator in Growth Hormone Research
Introduction
Michael Ankerson is a notable inventor based in Belle Mead, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the area of growth hormone regulation. His innovative work has led to the development of compounds that have potential therapeutic applications.
Latest Patents
Michael Ankerson holds a patent for "Growth hormone secretagogue receptor type 1A agonists." This patent involves compounds that act as ligands for the growth hormone secretagogue receptor type 1A (GHS-R 1A). These compounds, along with their pharmaceutically acceptable salts, are useful for the manufacture of medicaments aimed at regulating food intake.
Career Highlights
Ankerson is associated with Helsinn Therapeutics (U.S.), Inc., where he applies his expertise in drug development and innovation. His work focuses on creating effective treatments that can improve health outcomes related to growth hormone levels.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Michael Ankerson's contributions to the field of growth hormone research exemplify the impact of innovative thinking in medicine. His patent for GHS-R 1A agonists highlights the potential for new treatments that can help regulate food intake and improve health.